Turkish Journal of Biology
Most Popular Papers *
Targeting Mitochondrial and Inflammatory Pathways in Abdominal Aortic Aneurysm: Discovery of Sigma-1 and PPAR-γ Agonists through Plasma MicroRNA Profiling
DEFNE ÇIĞ KABAKCIOĞLU, İREM PEKER EYÜBOĞLU, MEDİ KORİ, FATMA BETÜL ÇELİK, SEMRA MELİS SOYER, MUSTAFA ÇALIŞKAN, CAN ERZİK, KAZIM YALÇIN ARGA, and CEYDA KASAVİ
Pages 404-416
Comparison of TNFα, IFNγ, and DSS in modeling inflammatory bowel disease in murine enteroids and assessment of the role of zonulin inhibitor larazotide acetate
SEMA NUR GÜR, BURCU PERVİN, MEHMET EMİN ŞEKER, and FATİMA AERTS KAYA
Pages 355-363
MSX2 is an ERα-associated transcription factor that sustains proliferative capacity and is associated with favorable prognosis in luminal breast cancer
GAMZE TURAN, ELİF KANSIZ, GÖZDE KORKMAZ, and HANDE ÖZKAN
Pages 389-403
Pifithrin-α enhances ex vivo hematopoietic stem cell expansion
NESLİHAN MERİÇ, PINAR ÇOLAKOĞLU ERKAN, and FATİH KOCABAŞ
Pages 327-338
Bioethical issues in genome editing by CRISPR-Cas9 technology
FATMA BETÜL AYANOĞLU, AYŞE ESER ELÇİN, and YAŞAR MURAT ELÇİN
Pages 110-120
Astaxanthin elicits a shared transcriptional core and divergent cell-type-specific responses in MCF-7 breast and OVCAR-3 ovarian carcinoma cells
DUYGU AYGÜNEŞ JAFARI
Pages 426-436
Design and synthesis of a novel benzoxazine-based fluorophore with potential for lipid droplet targeting in cancer cells
EDA AÇIKGÖZ, BURAK KUZU, and MUSTAFA ÇAKIR
Pages 377-388
Antiatopic dermatitis activity of Lissachatina fulica mucin: Network pharmacology analysis and experimental validation
ATIN SUPIYANI, WASMEN MANALU, LINA NOVIYANTI SUTARDI, MAWAR SUBANGKIT, and ANDRIYANTO ANDRIYANTO
Pages 259-273
Anti-Helicobacter pylori activity of polycation-coated PLGA nanoparticles loaded with juglone–silver complex
TURAL SAFAROV, EMRAH ŞEFİK ABAMOR, SERAP ACAR, MURAT TOPUZOĞULLARI, BÜKRE KIRAN ÜNER, KÜBRA KARADAŞ, SEÇİL KAYA, and ZİŞAN TOPRAK
Pages 339-354
* Based on the average number of full-text downloads per day since the paper was posted.
» Updated as of 10/25/26.
